Chemopreventive and hepatoprotective effects of Epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway

Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways

(2013) Jia Xiao et al.   EUROPEAN JOURNAL OF NUTRITION

Prostanoid EP1 receptor as the target of (−)-epigallocatechin-3-gallate in suppressing hepatocellular carcinoma cells in vitro

(2012) Juan Jin et al.   ACTA PHARMACOLOGICA SINICA

Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma

(2012) Seiki Miura et al.   BMC CANCER

Endothelium/nitric oxide mechanism mediates vasorelaxation and counteracts vasoconstriction induced by low concentration of flavanols

(2012) Annalisa Aggio et al.   EUROPEAN JOURNAL OF NUTRITION

(−)-Epigallocatechin-3-Gallate Induces Non-Apoptotic Cell Death in Human Cancer Cells via ROS-Mediated Lysosomal Membrane Permeabilization

(2012) Yin Zhang et al.   PLoS One

Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implications of CRP and lipid peroxides

(2012) ME El-Mesery et al.   Cell Division

Impact of Fibroblast Growth Factor-Binding Protein–1 Expression on Angiogenesis and Wound Healing

(2011) Elena Tassi et al.   AMERICAN JOURNAL OF PATHOLOGY

Sesame Oil Prevents Acute Kidney Injury Induced by the Synergistic Action of Aminoglycoside and Iodinated Contrast in Rats

(2011) Dur-Zong Hsu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity

(2011) Mohammed MH Al-Gayyar et al.   BRITISH JOURNAL OF PHARMACOLOGY

Pro-inflammatory effects of the mushroom Agaricus blazei and its consequences on atherosclerosis development

(2011) Juliana L. Gonçalves et al.   EUROPEAN JOURNAL OF NUTRITION

Fibroblast growth factor-2 enhances NK sensitivity of hepatocellular carcinoma cells

(2011) Hinako Tsunematsu et al.   INTERNATIONAL JOURNAL OF CANCER

Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview

(2011) Monica Marra et al.   Journal of Translational Medicine

Highly specific off-target binding identified and eliminated during the humanization of an antibody against FGF receptor 4

(2011) Daniela Bumbaca et al.   mAbs

Anti-tumor effects of fibroblast growth factor-binding protein (FGF-BP) knockdown in colon carcinoma

(2011) Daniel Schulze et al.   Molecular Cancer

Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases

(2011) Masahito Shimizu et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Cytotoxicity of iron oxide nanoparticles made from the thermal decomposition of organometallics and aqueous phase transfer with Pluronic F127

(2010) Marcela Gonzales et al.   Contrast Media & Molecular Imaging

Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor proNGF expression in a rat model of diabetes

(2010) M. M. H. Al-Gayyar et al.   DIABETOLOGIA

Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate

(2010) Steven D Rosen et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Quantitative and Qualitative Alterations of Heparan Sulfate in Fibrogenic Liver Diseases and Hepatocellular Cancer

(2010) Péter Tátrai et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Synergistic effects of tea polyphenols and ascorbic acid on human lung adenocarcinoma SPC-A-1 cells

(2010) Wei Li et al.   Journal of Zhejiang University-SCIENCE B

Novel chemotherapeutic and renal protective effects for the green tea (EGCG): Role of oxidative stress and inflammatory-cytokine signaling

(2010) A.M. El-Mowafy et al.   PHYTOMEDICINE

Heparanase and hepatocellular carcinoma: Promoter or inhibitor?

(2010) Shuo Dong   WORLD JOURNAL OF GASTROENTEROLOGY

Present and future possibilities for early diagnosis of hepatocellular carcinoma

(2010) Piotr Stefaniuk   WORLD JOURNAL OF GASTROENTEROLOGY

Signal Transducers and Activators of Transcription Mediate Fibroblast Growth Factor–Induced Vascular Endothelial Morphogenesis

(2009) Xinhai Yang et al.   CANCER RESEARCH

(-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis

(2009) Yohei Shirakami et al.   CANCER SCIENCE

The signaling mechanisms of syndecan heparan sulfate proteoglycans

(2009) Kathleen Lambaerts et al.   CURRENT OPINION IN CELL BIOLOGY

S6K1 deficiency protects against apoptosis in hepatocytes

(2009) Águeda González-Rodriguez et al.   HEPATOLOGY

EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells

(2009) Chi-Hung Huang et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Green tea polyphenol epigallocatechin-3-gallate inhibits thrombin-induced hepatocellular carcinoma cell invasion and p42/p44-MAPKinase activation

(2009) Kaufmann   ONCOLOGY REPORTS

Transcatheter Arterial Chemoembolization (TACE) in Hepatocellular Carcinoma (HCC): The Role of Angiogenesis and Invasiveness

(2008) Adriana Sergio et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells

(2008) Masahito Shimizu et al.   CANCER LETTERS

Epigallocatechin-3-gallate Inhibits Growth of Activated Hepatic Stellate Cells by Enhancing the Capacity of Glutathione Synthesis

(2008) Y. Fu et al.   MOLECULAR PHARMACOLOGY

EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer

(2007) Sharmila Shankar   Frontiers in Bioscience-Landmark